Illumina · 2 weeks ago
Engineer 1 - Development
San Diego, CA
Full-time
Onsite
New Grad, Entry Level
$68K/yr - $103K/yr
0+ years expIllumina is a company focused on expanding access to genomic technology to improve health equity. They are seeking a Development Engineer to fabricate and prototype micro- and nano-scale sensors and fluidic devices for DNA sequencing, contributing to the development of consumable substrates utilized in sequencing platforms.
BiotechnologyGeneticsHealth CareMedical
No H1B
Responsibilities
Fabrication of micro/nanoscale features and devices and testing their integration with chemical and biological systems; this requires working at internal and university cleanroom facilities
Physical device characterization (SEM, AFM, high resolution optical microscopy, etc) to understand failure modes
Design of experimental protocols and execution of experiments with a high level of attention to detail
Keeping detailed lab notebooks, preparing reports, invention disclosures, updates and summaries for managers and teams as directed
Qualification
Required
Typically requires 0 to 2 years of previous professional experience
B.S. in an engineering or science discipline (Nanoengineering, Chemical Engineering, Materials Science, Applied Physics, or a closely related field)
Hands on experience in cleanroom environment and familiarity with typical techniques for micro/nanofabrication and characterization
Basic knowledge of engineering principles and methods to perform entry-level professional engineering functions
Ability to design experiments and analyze limited to large amounts of data
Be able to think and adapt to a rapidly changing environment
Aptitude for independent research in addition to working well within a team
Preferred
Intense curiosity about the world around them
Demonstrated ability for digging deep into experimental methods and results
Benefits
Access to genomics sequencing
Family planning
Health/dental/vision
Retirement benefits
Paid time off
Company
Illumina
Illumina is an innovative technology and revolutionary assays aiming the analyze genetic variation and function.
5001-10000 employees
Funding
Current Stage
Public CompanyTotal Funding
$1.28BKey Investors
Bank of America
2024-09-06Post Ipo Debt· $500M
2023-01-04Post Ipo Debt· $750M
2000-07-28IPO
Leadership Team
Steven Barnard
Chief Technology Officer, Head of Research & Product Development
Jenny Lei Zheng
SVP & GM of Greater China
Recent News
2026-01-22
2026-01-20
2026-01-16
Company data provided by crunchbase